F18.980 Inhalant use, unspecified with inhalant-induced anxiety disorder

Name of the Condition

• Common Name: Inhalant Use Disorder with Inhalant-Induced Anxiety Disorder
• Medical Term: Inhalant Use, Unspecified with Inhalant-Induced Anxiety Disorder

Summary

Inhalant use, unspecified with inhalant-induced anxiety disorder, refers to the misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects, accompanied by anxiety symptoms directly resulting from inhalant use. This condition involves the intentional inhalation of substances like glue, paint thinners, or aerosols, which can lead to acute intoxication, dependence, or other substance-related complications. Inhalant use may result in significant physical and psychological harm, affecting an individual's health and daily functioning.

Causes

Inhalant use is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and related health issues, including anxiety disorders.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment or memory issues.
• Persistent anxiety, restlessness, or panic attacks.
• Physical symptoms like headaches, nausea, or tremors.

Diagnosis

Diagnosis involves a comprehensive evaluation of the patient's history, including patterns of inhalant use and the onset of anxiety symptoms. Clinical assessment may include screening for substance use disorders and anxiety disorders, with consideration of the temporal relationship between inhalant use and anxiety symptoms. Laboratory tests or imaging may be used to rule out other medical conditions contributing to anxiety.

Treatment Options

Treatment typically includes a combination of behavioral therapies, such as cognitive-behavioral therapy (CBT), to address inhalant use and anxiety. Medications may be prescribed to manage anxiety symptoms or withdrawal effects. Supportive care, including counseling and education, is often provided to help individuals reduce inhalant use and develop coping strategies.

Prognosis and Follow-Up

Prognosis depends on the severity of inhalant use and the individual's response to treatment. Early intervention improves outcomes, but relapse is possible. Regular follow-up is essential to monitor progress, adjust treatment plans, and address any ongoing anxiety or substance use issues.

Complications

• Worsening of anxiety symptoms or development of other mental health disorders.
• Physical health issues, such as organ damage or neurological problems.
• Social and occupational impairment due to substance use.
• Increased risk of accidental injury or overdose.

Lifestyle & Prevention

• Avoiding exposure to inhalants and educating others about their risks.
• Seeking healthy coping mechanisms for stress or anxiety.
• Engaging in supportive environments or peer groups focused on recovery.
• Maintaining open communication with healthcare providers about substance use concerns.

When to Seek Professional Help

Seek professional help if inhalant use is causing anxiety, affecting daily life, or leading to physical or psychological distress. Immediate care is needed for severe symptoms, such as intense panic attacks or signs of overdose.

Tips for Medical Coders

Document the presence of inhalant use and the specific inhalant-induced anxiety disorder to support accurate coding. Ensure clinical notes clearly describe the relationship between inhalant use and anxiety symptoms, as this is critical for assigning the correct code. Verify that the documentation aligns with the diagnostic criteria for both inhalant use and the anxiety disorder.